Molecular Therapy — Oncolytics · 2021 · 55 citations · 18 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyCancer ImmunotherapyGene Delivery To Immune CellsImmune Evasion In CancerImmunotherapy For Solid TumorsOncolytic Virus ImmunotherapyOncolytic Virus TherapyAntitumor Immune ActivationExosome PurificationExosome-based TherapyExosomesExtracellular VesiclesImmunosuppressive FunctionIntratumoral AdministrationTumor-derived Exosomes
Immunostimulatory gene therapy utilizing oncolytic viruses (OVs) as gene vehicles is a promising immunotherapy for cancer. Since viruses are immunogenic, systemic delivery can be troublesome due to neutralizing antibodies. Nevertheless, local delivery by intratumoral injection seems to induce systemic immune reactions. In this study, we demonstrate a novel mechanism of action of armed OV therapy suggesting that exosomes released by tumor cells infected with armed OV may participate to activate the immune system and this may also support systemic immunity. Tumor cell-derived exosomes commonly exert immunosuppressive functions. We hypothesized that exosomes derived from OV-infected tumor cells may instead be immunostimulatory. Human melanoma cells were infected by OVs armed with costimulatory molecules CD40 ligand (CD40L) and 4-1BB ligand (4-1BBL). Exosomes were purified and investigated for the presence of CD40L/4-1BBL mRNA and protein, and for their capacity to stimulate immune responses. The results show that the exosomes cargo transgenes. The exosomes from CD40L/4-1BBL-expressing tumor cells, or the viruses themselves, could stimulate robust dendritic cell (DC) activation with an enhanced level of major histocompatibility complex (MHC) and costimulatory molecules. Hence, exosomes after OV infection can locally activate immune responses at the tumor site and encounter immune cells such as DCs.
18
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen, Alexander C. Huang, Wei Zhang et al. · Nature · 2018 · 2.8K citations · Full text
Life Sciences, Immunology, Oncology +14
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas, Reinhard Dummer, Igor Puzanov et al. · Cell · 2017 · 1.5K citations · Full text
Medicine, Immunology, Oncology +12
Roberta Valenti, Veronica Huber, Paola Filipazzi et al. · Cancer Research · 2006 · 482 citations · Full text
Life Sciences, Immunology, Oncology +17
Decreased antigen presentation by dendritic cells in patients with breast cancer.
Dmitry I. Gabrilovich, Jadranco Corak, I. Frank Ciernik et al. · PubMed · 1997 · 437 citations
Life Sciences, Immunology, Oncology +17